GSK plc (LON:GSK)
London · Delayed Price · Currency is GBP · Price in GBX 1,976.50
+4.00 (0.20%)
Mar 19, 2026, 8:24 AM GMT
GSK plc Market Cap
GSK plc has a market cap or net worth of 78.94 billion as of March 18, 2026. Its market cap has increased by 30.57% in one year.
Market Cap
78.94B
Enterprise Value
92.89B
Revenue
32.67B
Ranking
n/a
PE Ratio
14.21
Stock Price
1,976.50
Market Cap Chart
Since December 27, 2000, GSK plc's market cap has increased from 64.68B to 78.94B, an increase of 22.05%. That is a compound annual growth rate of 0.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 17, 2026 | 80.58B | 10.08% |
| Dec 31, 2025 | 73.20B | 33.23% |
| Dec 31, 2024 | 54.94B | -7.05% |
| Dec 29, 2023 | 59.11B | 1.25% |
| Dec 30, 2022 | 58.38B | -27.44% |
| Dec 31, 2021 | 80.46B | 20.44% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 221.42B |
| Haleon | 34.39B |
| Smith & Nephew | 10.64B |
| Convatec Group | 4.56B |
| Hikma Pharmaceuticals | 2.81B |
| HUTCHMED (China) | 1.84B |
| Genus | 1.79B |
| Oxford Nanopore Technologies | 1.21B |